Australia Smart Inhalers Market Size & Outlook, 2023-2030

The smart inhalers market in Australia is expected to reach a projected revenue of US$ 366.2 million by 2030. A compound annual growth rate of 21.4% is expected of Australia smart inhalers market from 2024 to 2030.
Revenue, 2023 (US$M)
$94.4
Forecast, 2030 (US$M)
$366.2
CAGR, 2024 - 2030
21.4%
Report Coverage
Australia

Australia smart inhalers market highlights

  • The Australia smart inhalers market generated a revenue of USD 94.4 million in 2023 and is expected to reach USD 366.2 million by 2030.
  • The Australia market is expected to grow at a CAGR of 21.4% from 2024 to 2030.
  • In terms of segment, metered dose inhalers (mdis) was the largest revenue generating type in 2023.
  • Metered Dose Inhalers (MDIs) is the most lucrative type segment registering the fastest growth during the forecast period.


Smart inhalers market data book summary

Market revenue in 2023USD 94.4 million
Market revenue in 2030USD 366.2 million
Growth rate21.4% (CAGR from 2023 to 2030)
Largest segmentMetered dose inhalers (mdis)
Fastest growing segmentMetered Dose Inhalers (MDIs)
Historical data2017 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)
Key market players worldwideAptarGroup Inc, Adherium Ltd, Teva Pharmaceutical Industries Ltd, Propeller Health, Novartis AG ADR, 3M Co, H&T Presspart Manufacturing, Cohero Health, Cognita Labs, Amiko, Pneuma Respiratory, AireHealth, FindAir


Other key industry trends

  • In terms of revenue, Australia accounted for 0.6% of the global smart inhalers market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China smart inhalers market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,583.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Smart Inhalers Market Companies

Name Profile # Employees HQ Website

Australia smart inhalers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to smart inhalers market will help companies and investors design strategic landscapes.


Metered dose inhalers (mdis) was the largest segment with a revenue share of 66.74% in 2023. Horizon Databook has segmented the Australia smart inhalers market based on dry powdered inhalers (dpis), metered dose inhalers (mdis) covering the revenue growth of each sub-segment from 2017 to 2030.


Reasons to subscribe to Australia smart inhalers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia smart inhalers market databook

  • Our clientele includes a mix of smart inhalers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia smart inhalers market, including forecasts for subscribers. This country databook contains high-level insights into Australia smart inhalers market from 2017 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia smart inhalers market report size, by type, 2017-2030 (US$M)

Australia Smart Inhalers Market Share, 2023 & 2030 (US$M)

Australia smart inhalers market report size, by type, 2017-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more